Computational & In-Silico Drug Discovery CROs
31 published
31 published CROs match Computational & In-Silico Drug Discovery.
Locations in this set include United States, United Kingdom, China, India, Canada, and France.
Capabilities that show up most often in this set: Small Molecule, Antibody-Drug Conjugate (ADC), Peptide, Biologics (Monoclonal Antibodies), and Biologics (Other).
Matching companies
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
PozeSCAF Inc.Preclinical drug discovery CRO combining proprietary generative AI platform AxDrug with computational chemistry, synthetic chemistry, and in vitro biology to accelerate hit discovery and lead optimization for biotech and pharma clients.
Proone LabsProone Labs provides preclinical pharmacology, drug discovery, and regulatory support services to biotech startups, traditional pharma, and in-silico companies. The team has delivered 30+ assays, 50+ cell lines, and supported 4 FDA drug approvals across multiple therapeutic areas.
SelvitaSelvita is an integrated drug discovery and development service provider offering comprehensive solutions from target validation through preclinical candidate nomination and clinical manufacturing, with expertise in small molecules, antibodies, and protein degraders.
SteerOn ResearchDiscovery chemistry CRO offering computational, medicinal, synthetic, and analytical chemistry services alongside regulatory support including PDE/OEL assessments, genotoxicity evaluations, and pharmacovigilance for pharmaceutical and biotech clients.
Sygnature DiscoveryIntegrated drug discovery CRO covering target identification through lead optimization, with computational design, structural biology, medicinal chemistry and DMPK support. Serves biotech and pharma clients across the US, Canada, UK and Europe.
Synfini, Inc.Synfini provides AI-driven drug discovery services from target selection through lead optimization, combining cloud-based AI design tools with robotic wet lab automation to accelerate DMTA cycles across diverse chemical modalities and therapeutic indications.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Taros Chemicals GmbH & Co. KGIndependent chemistry CRO in Dortmund, Germany offering discovery chemistry, custom synthesis, medicinal chemistry, and process development for pharma, biotech, and chemical companies since 1999.
VipergenVipergen provides DNA-encoded library (DEL) screening services for hit identification in early-stage drug discovery, offering both in vitro and in-cell selection formats with high-fidelity libraries containing 500+ million drug-like molecules.
WuXi AppTecGlobal CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Markdown mirror: /services/computational-drug-discovery.md